Express Scripts Holding Shares Outstanding 2006-2018 | ESRX

Current and historical number of shares outstanding for Express Scripts Holding (ESRX) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.579B 25.43
PRA Health Sciences (PRAH) United States $6.569B 31.45
Charles River Laboratories (CRL) United States $5.954B 23.14
INC Research Holdings (SYNH) United States $5.160B 22.72
HealthEquity (HQY) United States $5.109B 108.34
Premier (PINC) United States $4.942B 19.99
Teladoc (TDOC) United States $4.273B 0.00
NovoCure (NVCR) Jersey $3.406B 0.00
AMN Healthcare Services Inc (AMN) United States $2.929B 22.34
Intrexon (XON) United States $1.907B 0.00
Medpace Holdings (MEDP) United States $1.705B 27.11
BioTelemetry (BEAT) United States $1.651B 45.77
IKang Healthcare (KANG) China $1.426B 78.96
Healthways (TVTY) United States $1.384B 19.60
Natera (NTRA) United States $1.234B 0.00
China Cord Blood (CO) China $1.034B 27.65
Apollo Medical Holdings (AMEH) United States $0.907B 0.00
Surgery Partners (SGRY) United States $0.692B 0.00
Civitas Solutions (CIVI) United States $0.601B 15.33
CareDx (CDNA) United States $0.441B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
Cancer Genetics (CGIX) United States $0.026B 0.00
Biocept (BIOC) United States $0.014B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.008B 0.00